Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry

Clinical Research in Cardiology

Volumn 106, Issue 6, 2017, Pages 436-443

  von Haehling, Stephan ^a   Gremmler, Uwe ^b   Krumm, Michael ^b   Mibach, Frank ^c   Schön, Norbert ^d   Taggeselle, Jens ^e   Dahm, Johannes B ^f   Angermann, Christiane E ^g  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b MVZ Ambulantes kardiologisches Zentrum   (Germany)

^c Gesundheitszentrum Klosterforst   (Germany)

^d Kardiologisch Angiologische Praxis   (Germany)

^e Kardiologische Praxis   (Germany)

^f Krankenhaus Neu Bethlehem   (Germany)

^g UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Anaemia; Exercise capacity; Heart failure; Iron deficiency; Prevalence

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CREATININE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FERRITIN; HEMOGLOBIN; TRANSFERRIN; IRON;

AGED; ANEMIA; ARTICLE; BLOOD PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; ELECTROCARDIOGRAM; EXERCISE; FEMALE; HEART FAILURE; HUMAN; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MILD RENAL IMPAIRMENT; PHYSICAL PERFORMANCE; PREVALENCE; THROMBOCYTE COUNT; BODY WEIGHT; CHRONIC DISEASE; DEFICIENCY; EXERCISE TOLERANCE; GERMANY; HEART LEFT VENTRICLE FUNCTION; METABOLISM; MIDDLE AGED; OUTPATIENT; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; REGISTER; RISK FACTOR; SEX FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANEMIA; BODY WEIGHT; C-REACTIVE PROTEIN; CHRONIC DISEASE; EXERCISE TOLERANCE; FEMALE; GERMANY; HEART FAILURE; HEMOGLOBINS; HUMANS; IRON; MALE; MIDDLE AGED; OUTPATIENTS; PREVALENCE; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SEX FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 85013441227     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-016-1073-y     Document Type: Article

References (29)

1. von Haehling S, Jankowska EA, van Veldhuisen DJ, Ponikowski P, Anker SD (2015) Iron deficiency and cardiovascular disease. Nat Rev Cardiol 12:659–669
2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P on behalt of the Authors/Task Force Members and Document Reviewers (2016) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the european society of cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur J Heart Fail 18:891–975
3. Andrews NC (1999) Disorders of iron metabolism. N Engl J Med 341:1986–1995
4. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. J Nutr 2001;131(Suppl 2):568S–579S
5. Turer AT, Malloy CR, Newgard CB, Podgoreanu MV (2010) Energetics and metabolism in the failing heart: important but poorly understood. Curr Opin Clin Nutr Metab Care 13:458–465
6. Wish JB (2006) Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol 1(Suppl 1):S4–S8
7. Pasricha SR, Flecknoe-Brown SC, Allen KJ, Gibson PR, McMahon LP, Olynyk JK, Roger SD, Savoia HF, Tampi R, Thomson AR, Wood EM, Robinson KL (2010) Diagnosis and management of iron deficiency anaemia: a clinical update. Med J Aust 193:525–532
8. Glaspy J, Cavill I (1999) Role of iron in optimizing responses of anemic cancer patients to erythropoietin. Int Soc Cell 13:461–473
9. Ebner N, von Haehling S (2013) Iron deficiency in heart failure: a practical guide. Nutrients 5:3730–3739
10. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, for the FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448
11. Ezekowitz JA, McAlister FA, Armstrong PW (2003) Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 107:223–225
12. Nanas JN, Matsouka C, Karageorgopoulos D, Leonti A, Tsolakis E, Drakos SG, Tsagalou EP, Maroulidis GD, Alexopoulos GP, Kanakakis JE, Anastasiou-Nana MI (2006) Etiology of anemia in patients with advanced heart failure. J Am Coll Cardiol 48:2485–2489
13. Jankowska EA, Rozentryt P, Witkowska A, Nowak J, Hartmann O, Ponikowska B, Borodulin-Nadzieja L, Banasiak W, Polonski L, Filippatos G, McMurray JJ, Anker SD, Ponikowski P (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31:1872–1880
14. Blanc B, Finch CA, Hallberg L, Nutritional anaemias (1968) Report of a WHO scientific group. WHO Tech Rep Ser 405:1–40
15. Opasich C, Cazzola M, Scelsi L, DeFeo S, Bosimini E, Lagioia R, Febo O, Ferrari R, Fucilli A, Moratti R, Tramarin R, Tavazzi L (2005) Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure. Eur Heart J 26:2232–2237
16. Adlbrecht C, Kommata S, Hu¨lsmann M, Szekeres T, Bieglmayer C, Strunk G, Karanikas G, Berger R, Mortl D, Kletter K, Maurer G, Lang IM, Pacher R (2008) Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body’s red cell volume. Eur Heart J 29:2343–2350
17. Schou M, Bosselmann H, Gaborit F, Iversen K, Goetze JP, Soletomas G, Rasmussen J, Kistorp C, Kober L, Gustafsson F, Tonder N (2015) Iron deficiency: prevalence and relation to cardiovascular biomarkers in heart failure outpatients. Int J Cardiol 195:143–148
18. Ebner N, Jankowska EA, Ponikowski P, Lainscak M, Elsner S, Sliziuk V, Steinbeck L, Kube J, Bekfani T, Scherbakov N, Valentova M, Sandek A, Doehner W, Springer J, Anker SD, von Haehling S (2016) The impact of iron deficiency and anaemia on exercise capacity and outcomes in patients with chronic heart failure. Results from the studies investigating co-morbidities aggravating heart failure. Int J Cardiol 205:6–12
19. Allen RP, Auerbach S, Bahrain H, Auerbach M, Earley CJ (2013) The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia. Am J Hematol 88:261–264
20. Pamuk GE, Top MŞ, Uyanık MŞ, Köker H, Akker M, Ak R, Yürekli ÖA, Çelik Y (2016) Is iron-deficiency anemia associated with migraine? Is there a role for anxiety and depression? Wien Klin Wochenschr 128(Suppl 8):576–580
21. Swedberg K, Young JB, Anand IS, Cehng S, Desai AS, Diaz R, Maggioni AP, MvMurray JJ, O’Connor,C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ, RED-HF Committees, RED- HF Investigators (2013) Treatment fo anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 368:1210–1219
22. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Mori C, von Eisenhart Rothe B, Pocock S, Poole-Wilson PA, Ponikowski P; FAIR-HF committees and investigators (2009) Rationale and design of ferinject assessment in patients with iron deficiency and chronic heart failure (Fair-HF) study: a randomized, placebo-controlled study of intravenous iron supplementation in patients with and without anaemia. Eur J Heart Fail 11:1084–1091
23. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361:2436–2448
24. Ponikowski P, van Veldhuisen DJ, Comin-Colet J, Ertl G, Komajda M, Mareev V, McDonagh TA, Parkhomenko A, Tavazzi L, Levesque V, Mori C, Roubert B, Filippatos G, Ruschitzka F, Anker SD (2014) Rationale and design of the CONFIRM-HF study: a double-blind, randomized, placebo-controlled study to assess the effects of intravenous ferric carboxymaltose on functional capacity in patients with chronic heart failure and iron deficiency. ESC Heart Failure 1:52–58
25. van Veldhuisen DJ, Ponikowski P, Metra M, Böhm M, van der Meer P, Doletsky A, Voors AA, Macdougall IC, Roubert B, Anker SD, Cohen Solal A. Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF): A Randomized, Controlled Study. http://www.abstractsonline.com/pp8/#!/4096/presentation/58426. Accessed 21 Nov 2016
26. Jankowska EA, Tkaczyszyn M, Suchocki T, Drozd M, von Haehling S, Doehner W, Banasiak W, Filippatos G, Anker SD, Ponikowski P (2016) Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: a meta-analysis of randomized controlled trials. Eur J Heart Fail 18:786–795
27. Clevenger B, Gurusamy K, Klein AA, Murphy GJ, Anker SD, Richards T (2016) Systematic review and meta-analysis of iron therapy in anaemic adults without chronic kidney disease: updated and abridged Cochrane review. Eur J Heart Fail 18:774–785
28. Lewis GD, Anstrom KJ, McNulty S, Hernandez AF, Braunwald E, for the NHLBI Heart Failure Network (2016) Oral iron repletion effects on oxygen uptake in heart failure (IRONOUT HF). http://www.abstractsonline.com/pp8/#!/4096/presentation/58425. Accessed 21 Nov 2016
29. Cohen-Solal A, Leclercq C, Mebazaa A, De Groote P, Damy T, Isnard R, Galinier M (2014) Diagnosis and treatment of iron deficiency in patients with heart failure: expert position paper from French cardiologists. Arch Cardiovasc Dis 107:563–571